Stocktoria
Bio Essence Corp BIOE
Bio Essence Corp (BIOE) earns a Piotroski F-score of 9/9 (strong financial health). It does not currently pay a dividend. FY2025 revenue was $1.9M at a 47.2% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Manufacturing · percentile among 1965 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 9/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| BIOE | Bio Essence Corp | 9/9 | — | 14.1 | — |
| LPCN | Lipocine Inc. | — | — | — | -82.3% |
| ORMP | ORAMED PHARMACEUTICALS INC. | 2/9 | 7.8 | 3 | — |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 1/9 | 14.17 | — | — |
| CYCN | Cyclerion Therapeutics, Inc. | 1/9 | — | — | — |
| CLSDQ | Clearside Biomedical, Inc. | 2/9 | — | — | — |
| RANI | Rani Therapeutics Holdings, Inc. | 4/9 | -4.67 | — | — |
About Bio Essence Corp
Bio Essence Corporation engages in manufacturing and distributing health supplement products. It also offers original equipment manufacturing, and private label services for dietary supplements, vitamins, and herbal nutrition products. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California.
FAQ
Is BIOE financially healthy?
Bio Essence Corp's Piotroski F-score is 9/9 (8–9 is excellent, 0–3 weak).
Does BIOE pay a dividend?
No, Bio Essence Corp does not currently pay a dividend.
How profitable is BIOE?
In FY2025, Bio Essence Corp had a net margin of 47.2%.
What is BIOE's P/E ratio?
Bio Essence Corp's trailing price-to-earnings (P/E) ratio is about 14.1×, based on its latest annual earnings.
Is BIOE a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Bio Essence Corp: a Piotroski F-score of 9/9, a P/E of about 14.1×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.